Rapid weight loss itself can trigger temporary mood fluctuations due to changes in leptin, cortisol, and estrogen metabolism
Ramesh Hariharan, CEO and co-founder, Strand Life Sciences, Bengaluru, Indias leading genomic testing company
Current GLP-1 drugs personal injury lawsuits primarily involve medications like Ozempic, Wegovy, Rybelsus (semaglutide), and Mounjaro (tirzepatide)
Inositol shows the strongest evidence in PCOS populations, with modest BMI reduction in meta-analyses
FDA-approved for type 2 diabetes as Mounjaro (2022) and for chronic weight management as Zepbound (2023)
Some medications used to treat sleep disturbances include: clonidine, trazodone, melatonin, and antihistamines